News
Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed ...
As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...
Hosted at nonprofit incubator and accelerator Winston Starts, The Founders’ Journey focused on venture-backed biotechnology ...
1h
24/7 Wall St. on MSNPrediction: 1 Biotech Stock That Could Surpass Pfizer by 2030Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...
YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and ...
Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...
Biotech entrepreneur Sam Waksal has been accused of "reckless conduct," including using a veterinary medicine on a severely ...
Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...
During the review, Dr. Singh lauded the Department of Biotechnology and BIRAC for their consistent contributions to medical ...
The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...
GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results